Premier Health Clinical Research is a network of operating infusion centers, purpose-upgraded for clinical trial conduct. IV infrastructure, trained nursing staff, investigational pharmacy, and active patient populations — already in place.
Every Premier Health site is a working infusion center — IV-trained nurses, monitored infusion chairs, and an on-site pharmacy already caring for patients every day. Research runs on infrastructure that is proven, not provisional.
Explore the Infusion Advantage →Infusion chairs, IV-trained nursing staff, vital-sign monitoring, and adverse-event response protocols are standard at every location — not add-ons.
Controlled-temperature storage, chain-of-custody documentation, and controlled-substance handling built into existing pharmacy operations.
Active infusion patient populations provide a direct, in-house recruitment pipeline — enrollment starts from an existing base, not a cold start.
We conduct Phase II–IV trials across multiple therapeutic areas, with particular strength in conditions where infusion-based care is already part of the treatment landscape.
Biologic and infusion-delivered therapies for autoimmune and inflammatory conditions.
Infusion-based treatments for neurological and neurodegenerative disease.
Renal and related conditions managed through infusion protocols.
IBD and other conditions where biologic infusions are standard of care.
Metabolic and endocrine studies leveraging established patient populations.
IV antimicrobial and emerging-therapy trials.
Infusion-delivered therapies for blood and related disorders.
Our infrastructure scales across additional therapeutic areas as the network grows.
Fast feasibility responses, quick contract turnaround, and speed from execution to first patient screened — with real-time CTMS visibility into site performance.
Our centers offer access for the administration of infusion-based investigational products — expertly prepared and delivered by our clinical nursing staff, in collaboration with your physician investigators and research coordinators.
Talk to our team about placing your next Phase II–IV trial on a purpose-upgraded infusion center network.